120 related articles for article (PubMed ID: 15357482)
21. Carbocisteine for acute exacerbations of COPD.
Mohapatra PR; Aggarwal D
Lancet; 2008 Nov; 372(9650):1630-1; author reply 1631-2. PubMed ID: 18994656
[No Abstract] [Full Text] [Related]
22. Mucolytic agents versus placebo for chronic bronchitis or chronic obstructive pulmonary disease: A Cochrane review summary.
Murray AS
Int J Nurs Stud; 2021 Dec; 124():103711. PubMed ID: 32732157
[No Abstract] [Full Text] [Related]
23. [Fluoroquinolone superior to macrolide. Longer infection free period after acute bronchitis].
MMW Fortschr Med; 2003 Feb; 145(7):63. PubMed ID: 12652830
[No Abstract] [Full Text] [Related]
24. Carbocisteine improves quality of life in patients with chronic obstructive pulmonary disease.
Tatsumi K; Fukuchi Y;
J Am Geriatr Soc; 2007 Nov; 55(11):1884-6. PubMed ID: 17979906
[No Abstract] [Full Text] [Related]
25. A double-blind crossover study comparing the safety and efficacy of three weeks of Flu/Sal 250/50 bid plus albuterol 180 ug prn q4 hours to Flu/Sal 250/50 bid plus albuterol/Ipratropium bromide 2 puffs prn q4 hours in patients with chronic obstructive pulmonary disease.
Balkissoon R; Make B
COPD; 2008 Aug; 5(4):221-7. PubMed ID: 18671147
[TBL] [Abstract][Full Text] [Related]
26. [Bronchodilators in chronic obstructive pulmonary disease (COPD)].
Gillissen A; Buhl R; Rabe KF; Vogelmeier C; Welte T
Med Klin (Munich); 2005 May; 100(5):246-54. PubMed ID: 15902378
[TBL] [Abstract][Full Text] [Related]
27. [Oxytetracycline + myrtol standardized in sinusitis and bronchitis. General practice test passed with "very good"].
MMW Fortschr Med; 2006 Jan; 148(1-2):49. PubMed ID: 16610419
[No Abstract] [Full Text] [Related]
28. [Use and misuse of antibacterial agents in chronic bronchitis].
Brubakk O; Walstad RA
Tidsskr Nor Laegeforen; 2003 May; 123(10):1355-6. PubMed ID: 12806677
[No Abstract] [Full Text] [Related]
29. [Withdrawal of fluticasone propionate from combined salmeterol/fluticasone treatment in patients with COPD causes immediate and sustained disease deterioration: a randomised controlled trial].
Wouters EF; Postma DS; Fokkens B; Hop WC; Prins J; Kuipers AF; Pasma HR; Hensing CA; Creutzberg EC;
Rev Port Pneumol; 2005; 11(6):587-9. PubMed ID: 16514718
[No Abstract] [Full Text] [Related]
30. Development of a COPD severity score.
Wu EQ; Birnbaum HG; Cifaldi M; Kang Y; Mallet D; Colice G
Curr Med Res Opin; 2006 Sep; 22(9):1679-87. PubMed ID: 16968571
[TBL] [Abstract][Full Text] [Related]
31. Comparative efficacy of once daily, 5-day short-course therapy with clarithromycin extended-release versus twice daily, 7-day therapy with clarithromycin immediate-release in acute bacterial exacerbation of chronic bronchitis.
Gotfried M; Notario G; Spiller J; Palmer R; Busman T
Curr Med Res Opin; 2005 Feb; 21(2):245-54. PubMed ID: 15801995
[TBL] [Abstract][Full Text] [Related]
32. [Letosteine in chronic obstructive bronchopneumopathy].
Meroni P; Palmieri G; De Bartolo G; Barcellini W; Albrici A; Froldi M
Clin Ter; 1983 Apr; 105(2):109-18. PubMed ID: 6345052
[No Abstract] [Full Text] [Related]
33. [Inhaled corticosteroids in patients with COPD: maintain current guidelines].
Heijdra YF
Ned Tijdschr Geneeskd; 2007 Oct; 151(40):2195-7. PubMed ID: 17969568
[TBL] [Abstract][Full Text] [Related]
34. [Acetylcysteine in chronic obstructive pulmonary disease. Secretolytic, antioxidant or placebo?].
Randerath W; Galetke W
Med Monatsschr Pharm; 2003 Nov; 26(11):375-8. PubMed ID: 14652922
[No Abstract] [Full Text] [Related]
35. [Is therapy for lung diseases with secretolytics useful?].
Gillissen A
Dtsch Med Wochenschr; 2009 Jun; 134(23):1237. PubMed ID: 19472097
[No Abstract] [Full Text] [Related]
36. [Acute bronchitis: really not a case for antibiotics?] [Interview by Barbara Kreutzkamp].
Gillissen A
MMW Fortschr Med; 2005 Feb; 147(8):13. PubMed ID: 18441557
[No Abstract] [Full Text] [Related]
37. External validity of randomized controlled trials in COPD.
Travers J; Marsh S; Caldwell B; Williams M; Aldington S; Weatherall M; Shirtcliffe P; Beasley R
Respir Med; 2007 Jun; 101(6):1313-20. PubMed ID: 17113277
[TBL] [Abstract][Full Text] [Related]
38. [Clinicomicrobiological monitoring of patients with exacerbation of chronic bronchitis treated with antibacterial drugs].
Dvoretskiĭ LI; Dubrovskaia NV; Grudinina SA; Filimonova OIu; Iakovlev SV; Sergeeva EV; Sidorenko SV
Ter Arkh; 2006; 78(3):25-35. PubMed ID: 17019954
[TBL] [Abstract][Full Text] [Related]
39. Oral bacterial vaccines for the prevention of acute exacerbations in chronic obstructive pulmonary disease and chronic bronchitis.
Arandjus C; Black PN; Poole PJ; Wood Baker R; Steurer-Stey C
Respir Med; 2006 Oct; 100(10):1671-81. PubMed ID: 16934969
[TBL] [Abstract][Full Text] [Related]
40. Pharmacologic treatments for chronic obstructive pulmonary disease: a mixed-treatment comparison meta-analysis.
Baker WL; Baker EL; Coleman CI
Pharmacotherapy; 2009 Aug; 29(8):891-905. PubMed ID: 19637942
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
